Polaris Market Research has published insightful research on Hematologic Malignancies Therapeutics Market. The research report offers an in-depth analysis of the market, covering all the major aspects, including market size, market share, growth drivers, and key trends. Besides, a thorough assessment of the annual forecast, strategies, and potential roadmaps has been provided in the...

Valued at USD 71.38 billion in 2024, the hematologic malignancies therapeutics market is projected to reach USD 76.63 billion in 2025 and USD 148.15 billion by 2034, growing at a CAGR of 7.6% during the forecast period 2025–2034. North America held the largest regional position in 2024. Key players include AbbVie Inc., Amgen Inc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd.,...